← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aventusoft, Llc
Boca Raton, FL
$12,207,771
Total funding
10
Grants
Funding over time
peak $3.4M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,207,771 · 10
By mechanism
R44$10,348,817 · 4
R43$1,009,099 · 4
SB1$500,000 · 1
R41$349,855 · 1
Investigators at Aventusoft, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus$1,500,000
R44 · FY2021 · HL
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients$1,500,000
R44 · FY2021 · HL
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients$1,500,000
R44 · FY2020 · HL
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus$1,500,000
R44 · FY2022 · HL
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.$864,759
R44 · FY2024 · HL
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.$860,397
R44 · FY2025 · HL
Commercialization Readiness Pilot Program support for: HATS-OFF$500,000
SB1 · FY2025 · HL
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals$400,000
R44 · FY2017 · MD
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals$400,000
R44 · FY2018 · MD
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals$400,000
R44 · FY2019 · MD
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus$400,000
R44 · FY2020 · HL
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.$399,999
R44 · FY2023 · HL
An Innovative AI-Powered Wearable Physiological Sensor System for Real-Time Pain Monitoring and Management (PainVitals)$349,855
R41 · FY2025 · GM
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients$225,001
R44 · FY2019 · HL
Innovative, non-invasive, battery-less, disposable cardiac biosensor for hemodynamic monitoring$225,000
R43 · FY2021 · EB
Innovation for the earlydetection, diagnosis, and quantification of diabetic cardiomyopathy.$225,000
R43 · FY2017 · DK
A mobile framework to measure ejection fraction by automated non-invasive analysi$200,000
R43 · FY2014 · MD
A mobile framework to measure ejection fraction by automated non-invasive analysi$200,000
R43 · FY2015 · MD
Screening Under REgular assessment with hemoTAG (SURE TAG)$189,746
R44 · FY2020 · HL
Administrative Supplement to Promote Diversity in Research and Development Small Businesses-SBIR (Rodrigo Jordao)$134,079
R44 · FY2021 · HL